Clinical Trial Update: Safety and Pharmacokinetic Study of BIO 300 Capsules [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of BIO 300 capsules completed, reporting safety and pharmacokinetic data in Acute Radiation Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Syndrome

Drugs mentioned

• BIO 300

Snippet

Sponsor: Humanetics Corporation | Conditions: Acute Radiation Syndrome | Phase 1 | Status: COMPLETED